Mass tort litigation in September 2026 is concentrated in a small number of very large federal dockets, and the honest answer to most reader questions is that filing is fast while payment is slow. The U.S.
Judicial Panel on Multidistrict Litigation counts 162 active multidistrict litigations holding 205,540 pending actions, and 21 proceedings with 1,000 or more cases each account for more than 94% of that total. A multidistrict litigation, or MDL, is a federal procedure that gathers similar lawsuits before one judge for pretrial work; cases stay individual and can return to their home courts for trial. This FAQ answers the questions readers most often bring to that structure: which dockets are actually large, which are still taking new cases, which have money moving, and what a pending MDL does and does not do for your own deadline.
Table of Contents
- Which mass torts are actually large right now?
- Is it too late to file?
- Where is settlement money actually moving?
- What do bellwether trials tell you about your own case?
- Camp Lejeune is not an MDL, and that changes everything
- Frequently Asked Questions
Which mass torts are actually large right now?
Size is lopsided. According to the JPML's pending-actions report, 21 dockets hold the overwhelming majority of the 205,540 federal cases, so a "growing mass tort" you read about may hold a few dozen filings. The largest by a wide margin is MDL 2738, the Johnson & Johnson talcum powder litigation in the District of New Jersey.
MDL Update puts it at roughly 69,250 pending cases as of September 1, 2026, up from about 68,000 in June — an annual growth rate near 3.6%, which is slow for a docket that size and suggests intake has largely run its course. Behind it, the AFFF firefighting foam litigation in the District of South Carolina (MDL 2873) holds 15,264 claims, the hair relaxer litigation (MDL 3060) holds 11,779, and the Depo-Provera meningioma litigation (MDL 3140) holds 6,403. Roundup's MDL 2741, once a headline docket, is down to about 4,464 pending actions.
Is it too late to file?
That depends on the docket, and the difference is sharp. Hair relaxer is the largest MDL still accepting new filings after AFFF closed its intake window in September 2025, according to LeadGen Economy's 2026 intake analysis. A closed intake window does not bar a lawsuit outright, but it removes the streamlined path most firms rely on.
The deadline that actually controls your case is your state's statute of limitations — the fixed period after injury or discovery in which suit must be filed. A pending MDL does not pause it for someone who has not filed. That distinction costs claims every year.
- Confirm which state's law applies to you, since it is often where you were injured, not where you live now.
- Ask any firm you speak to whether the MDL still accepts direct filing, or whether your case must be filed in a district court first.
- Get the date of diagnosis in writing; discovery-rule deadlines usually run from it.
Where is settlement money actually moving?
Three answers, all different. In the talc litigation, Johnson & Johnson announced in July 2026 a roughly $5.5 billion resolution negotiated inside the ordinary tort system, after three failed bankruptcy attempts using the "Texas two-step" — a maneuver that moves liabilities into a new entity that then files Chapter 11. Lawsuit Informer's September 2026 update notes the deal does not cover every filed claim, and state-court trials have continued to produce verdicts. Depo-Provera moved faster than most observers expected.
Judge M. Casey Rodgers confirmed on June 15, 2026 a global agreement in principle between Pfizer and lead counsel to resolve eligible meningioma claims, and vacated the December 7, 2026 bellwether deadlines in *Toney v. Pfizer* — a docket that reached a settlement framework before its first trial. AFFF is the counterexample. Municipal water-system claims settled, but Drugwatch reports no personal-injury settlement exists, and the October 2025 kidney-cancer bellwether was vacated on August 15, 2025, pushing a global personal-injury resolution to 2026–2027 at the earliest.
What do bellwether trials tell you about your own case?
A bellwether is a test case tried early so both sides can price the rest. In the hair relaxer MDL, Judge Mary Rowland selected a ten-case pool and deliberately excluded claims with confounding complications — other plausible causes of the cancer — so the first verdicts test the uterine and ovarian cancer theories on clean facts. That design cuts both ways for an individual claimant.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
A strong verdict on clean facts is a strong signal for the litigation, but your case may carry exactly the complications the pool excluded, and it will be valued accordingly. Plaintiffs' counsel quoted by Miller & Zois estimate typical uterine cancer claims at $150,000 to $750,000, with most toward the low end. Treat any range like that as a planning figure, not a promise. Settlement values inside a large docket are usually tiered by injury severity, exposure duration, and documentation quality, and the cases at the top of a published range are rarely typical.
Camp Lejeune is not an MDL, and that changes everything
Camp Lejeune water contamination claims run under the Camp Lejeune Justice Act of 2022, through the Navy's Camp Lejeune Claims Unit and the Eastern District of North Carolina. Claimants must file an administrative claim with the Navy and wait six months before filing suit — a step with no equivalent in the MDL dockets above. The scale of the backlog is the headline fact. More than 410,000 administrative claims and about 3,700 federal lawsuits are pending, and as of July 17, 2026 settlement offers exceeded $968 million with payouts above $801 million, according to Miller & Zois' settlement tracking.
That is under 1% of claimants paid. The reason is documentary, not legal. Most Elective Option claims — the expedited tier with fixed payments tied to specific diagnoses and exposure periods — lack the proof needed to reach the Department of Justice. Service records, base residency evidence, and dated diagnosis records are what move a claim out of the queue.
Frequently Asked Questions
Does a pending MDL protect my claim if I have not filed yet?
No. The MDL governs cases already filed; your state's statute of limitations continues to run against you independently, which is why the JPML's docket counts say nothing about your personal deadline.
Why is talc's case count barely growing if it is the biggest MDL?
At roughly 3.6% annual growth on about 69,250 cases, intake has largely matured. Large dockets typically slow once the injury is widely known and filing deadlines have passed for early-exposure claimants.
What does "agreement in principle" mean for Depo-Provera claimants?
It means Pfizer and lead counsel have agreed on a framework to resolve eligible meningioma claims, and the court vacated the bellwether schedule accordingly. Individual eligibility and payment terms are worked out afterward.
If AFFF water-system claims settled, why has no personal-injury money moved?
They are separate tracks. Municipal water providers settled their contamination claims, while individual cancer claims still await a bellwether trial after the October 2025 kidney-cancer case was vacated.
You Might Also Like
- Defendants Mass Tort Litigation FAQ for September 2026: Source-Checked Answers to Common Questions
- Comparisons Mass Tort Litigation FAQ for September 2026: Source-Checked Answers to Common Questions
- What Is New With Demographic Guides Mass Tort Litigation in September 2026? Latest court filings and agency notices and Key Takeaways